Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Viral Vectors for Dendritic Cell-Based Immunotherapy

  • Chapter
Dendritic Cells and Virus Infection

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 276))

Abstract

Dendritic cells (DCs) constitute a specialised system of antigen-presenting cells with a high capacity to induce and to modulate the immune response against microbial, tumour and self-antigens. New techniques to generate large amounts of DCs together with the molecular identification of human tumour-associated antigens (TAA) have opened new ways for antigen-specific cancer immunotherapies. DCs loaded either with TAA-derived MHC class I-specific synthetic peptides or with whole tumour cell preparations have been used in numerous clinical trials evaluating the efficacy of DCs in patients with cancer. However, the disadvantages of DCs pulsed with synthetic peptides from TAA include the uncertainty regarding the longevity of antigen presentation, the restriction by the patient’s haplotype and the relatively low number of known MHC class I and in particular of MHC class II helper cell-related epitopes. Whole tumour cell preparations are difficult to standardise, and they depend on the availability of tumour cells. Thus the utilisation of viral vectors genetically modified to express TAA for the ex vivo transduction of DCs is an attractive alternative to achieve a MHC I- and MHC II-restricted presentation of tumoural antigens. To induce protective anti-tumoural immune response an increasing number of modified viral vectors have been used to transduce DCs. Although high transduction efficacies were reported for several viruses, analysis of the interaction of viral vectors with DCs has revealed several viral mechanisms that interfere with main functions of DCs, dampening somewhat the initial optimism in the field of DC transduction. However, promising results with different vectors have been achieved. In this review we summarise available data and discuss advantages and drawbacks of currently available vectors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ace CI, McKee TA, Ryan JM, Cameron JM, Preston CM: Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression. J.Virol. 1989, 63: 2260–2269.

    PubMed  CAS  Google Scholar 

  • Albert ML, Sauter B, Bhardwaj N: Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998, 392: 86–89.

    Article  PubMed  CAS  Google Scholar 

  • Alcami A, Koszinowski UH: Viral mechanisms of immune evasion. Immunol.Today 2000, 21: 447–455.

    Article  PubMed  CAS  Google Scholar 

  • Alcami A, Smith GL: A soluble receptor for interleukin-1 beta encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection. Cell 1992, 71: 153–167.

    Article  PubMed  CAS  Google Scholar 

  • Banchereau J, Schuler-Thurner B, Palucka AK, Schuler G: Dendritic cells as vectors for therapy. Cell 2001, 106: 271–274.

    Article  PubMed  CAS  Google Scholar 

  • Bender A, Albert M, Reddy A, Feldman M, Sauter B, Kaplan G, Hellman W, Bhardwaj N: The distinctive features of influenza virus infection of dendritic cells. Immunobiology 1998, 198: 552–567.

    Article  PubMed  CAS  Google Scholar 

  • Bender A, Bui LK, Feldman MA, Larsson M, Bhardwaj N: Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J.Exp.Med. 1995, 182: 1663–1671.

    Article  PubMed  CAS  Google Scholar 

  • Brossart P, Goldrath AW, Butz EA, Martin S, Bevan MJ: Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J Immunol 1997, 158: 3270–3276.

    PubMed  CAS  Google Scholar 

  • Brown M, Davies DH, Skinner MA, Bowen G, Hollingsworth SJ, Mufti GJ, Arrand JR, Stacey SN: Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectors. Cancer Gene Ther. 1999, 6: 238–245.

    Article  PubMed  CAS  Google Scholar 

  • Carroll MW, Moss B: Poxviruses as expression vectors. Curr.Opin.Biotechnol. 1997, 8: 573–577.

    Article  PubMed  CAS  Google Scholar 

  • Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A: Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J.Exp.Med. 1999, 189: 821–829.

    Article  PubMed  CAS  Google Scholar 

  • Chiriva-Internati M, Liu Y, Salati E, Zhou W, Wang Z, Grizzi F, Roman JJ, Lim SH, Hermonat PL: Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells. Eur.J.Immunol. 2002, 32: 30–38.

    Article  PubMed  CAS  Google Scholar 

  • Chou J, Kern ER, Whitley RJ, Roizman B: Mapping of herpes simplex virus-1 neuro-virulence to gamma 134.5, a gene nonessential for growth in culture. Science 1990, 250: 1262–1266.

    Article  PubMed  CAS  Google Scholar 

  • Diao J, Smythe JA, Smyth C, Rowe PB, Alexander IE: Human PBMC-derived dendritic cells transduced with an adenovirus vector induce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro. Gene Ther. 1999, 6: 845–853.

    Article  PubMed  CAS  Google Scholar 

  • Dietz AB, Bulur PA, Brown CA, Pankratz VS, Vuk-Pavlovic S: Maturation of dendritic cells infected by recombinant adenovirus can be delayed without impact on transgene expression. Gene Ther. 2001, 8: 419–423.

    Article  PubMed  CAS  Google Scholar 

  • Dietz AB, Vuk-Pavlovic S: High efficiency adenovirus-mediated gene transfer to human dendritic cells. Blood 1998, 91: 392–398.

    PubMed  CAS  Google Scholar 

  • Drexler I, Antunes E, Schmitz M, Wolfel T, Huber C, Erfle V, Rieber P, Theobald M, Sutter G: Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase-and melanoma-specific human leukocyte antigen A*020 1 -restricted cytotoxic T cells in vitro and in vivo. Cancer Res. 1999, 59: 4955–4963.

    PubMed  CAS  Google Scholar 

  • Drillien R, Spehner D, Bohbot A, Hanau D: Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes. Virology 2000, 268: 471–81.

    Article  PubMed  CAS  Google Scholar 

  • Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L: A third-generation lentivirus vector with a conditional packaging system. J.Virol. 1998, 72: 8463–8471.

    PubMed  CAS  Google Scholar 

  • Dyall J, Latouche JB, Schnell S, Sadelain M: Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes. Blood 2001, 97: 114–121.

    Article  PubMed  CAS  Google Scholar 

  • Fink DJ, Glorioso JC: Herpes simplex virus-based vectors: problems and some solutions. Adv.Neurol. 1997, 72: 149–156.

    PubMed  CAS  Google Scholar 

  • Firat H, Zennou V, Garcia-Pons F, Ginhoux F, Cochet M, Danos O, Lemonnier FA, Langlade-Demoyen P, Charneau P: Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy. J.Gene Med. 2002, 4: 38–45.

    Article  PubMed  Google Scholar 

  • Foley HD, Otero M, Orenstein JM, Pomerantz RJ, Schnell MJ: Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells. J.Virol. 2002, 76: 19–31.

    Article  PubMed  CAS  Google Scholar 

  • Frankel AD, Young JA: HIV-1: fifteen proteins and an RNA. Annu.Rev.Biochem. 1998, 67: 1–25.

    Article  PubMed  CAS  Google Scholar 

  • Geller AI: Herpes simplex virus-1 plasmid vectors for gene transfer into neurons. Adv.Neurol. 1997, 72: 143–148.

    PubMed  CAS  Google Scholar 

  • Gruber A, Kan-Mitchell J, Kuhen KL, Mukai T, Wong-Staal F: Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. Blood 2000, 96: 1327–1333.

    PubMed  CAS  Google Scholar 

  • Harris NL, Ronchese F: The role of B7 costimulation in T-cell immunity. Immunol.Cell Biol. 1999, 77: 304–311.

    Article  PubMed  CAS  Google Scholar 

  • Hayward AR, Read GS, Cosyns M: Herpes simplex virus interferes with monocyte accessory cell function. J.Immunol. 1993, 150: 190–196.

    PubMed  CAS  Google Scholar 

  • Holzer GW, Remp G, Antoine G, Pfleiderer M, Enzersberger OM, Emsenhuber W, Hammerle T, Gruber F, Urban C, Falkner FG, Dorner F: Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression. J.Virol. 1999, 73: 4536–4542.

    PubMed  CAS  Google Scholar 

  • Horig H, Lee DS, Conkright W, Divito J, Hasson H, LaMare M, Rivera A, Park D, Tine J, Guito K, Tsang KW, Schlom J, Kaufman HL: Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule. Cancer Immunol.Immunother. 2000, 49: 504–514.

    Article  PubMed  CAS  Google Scholar 

  • Horwitz MS: Adenoviruses. In Fields Virology. Edited by Fields BN, Knipe DM, Howley PM, Chancrock RM. Philadelphia: 1996: 2149–2171.

    Google Scholar 

  • Ignatius R, Marovich M, Mehlhop E, Villamide L, Mahnke K, Cox WI, Isdell F, Frankel S, Mascola JR, Steinman RM, Pope M: Canarypox-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor-a secretion. J.Virol. 2000, 74: 11329–11338.

    Article  PubMed  CAS  Google Scholar 

  • Ilan Y, Droguett G, Chowdhury NR, Li Y, Sengupta K, Thummala NR, Davidson A, Chowdhury JR, Horwitz MS: Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc.Natl.Acad.Sci.U.S.A 1997, 94: 2587–2592.

    Article  PubMed  CAS  Google Scholar 

  • Imler JL: Adenovirus vectors as recombinant viral vaccines. Vaccine 1995, 13:1143– 1151.

    Google Scholar 

  • Jenne L, Bhardwaj N: Perspectives of DC based immunotherapies. In Principles and Practice of Oncology, 6th Edition, Edited by DeVita VT, Hellman S, Rosenberg SA. Lippincott Williams & Wilkins; 2001: 1–15.

    Google Scholar 

  • Jenne L, Hauser C, Arrighi JF, Saurat JH, Hugin AW: Poxvirus as a vector to trans-duce human dendritic cells for immunotherapy: abortive infection but reduced APC function. Gene Ther 2000, 7: 1575–83.

    Article  PubMed  CAS  Google Scholar 

  • Jenne L, Schuler G, Steinkasserer A: Viral vectors for dendritic cell-based immunotherapy. Trends Immunol 2001, 22: 102–107.

    Article  PubMed  CAS  Google Scholar 

  • Jonuleit H, Giesecke-Tuettenberg A, Tuting T, Thurner-Schuler B, Stuge TB, Paragnik L, Kandemir A, Lee PP, Schuler G, Knop J, Enk AH: A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int.J.Cancer 2001, 93: 243–251.

    Article  PubMed  CAS  Google Scholar 

  • Kafri T: Lentivirus vectors: difficulties and hopes before clinical trials. Curr.Opin.- Mol.Ther. 2001, 3: 316–326.

    PubMed  CAS  Google Scholar 

  • Kochanek S, Schiedner G, Volpers C: High-capacity ‘gutless’ adenoviral vectors. Curr.Opin.Mol.Ther. 2001, 3: 454–463.

    PubMed  CAS  Google Scholar 

  • Kovesdi I, Brough DE, Bruder JT, Wickham TJ: Adenoviral vectors for gene transfer. Curr.Opin.Biotechnol. 1997, 8: 583–589.

    Article  PubMed  CAS  Google Scholar 

  • Kruse M, Rosorius O, Kratzer F, Bevec D, Kuhnt C, Steinkasserer A, Schuler G, Hau-ber J: Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA. J.Exp.Med. 2000a, 191:1581– 1590.

    Google Scholar 

  • Kruse M, Rosorius O, Kratzer F, Stelz G, Kuhnt C, Schuler G, Hauber J, Steinkasserer A: Mature dendritic cells infected with herpes simplex virus type I exhibit inhibited T cell stimulatory capacity. J.Virol. 2000b, 74: 7127–7136.

    Article  PubMed  CAS  Google Scholar 

  • Kwong AD, Frenkel N: The herpes simplex virus virion host shutoff function. J.Virol. 1989, 63: 4834–4839.

    PubMed  CAS  Google Scholar 

  • Lewis PF, Emerman M: Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J.Virol. 1994, 68: 510–516.

    PubMed  CAS  Google Scholar 

  • Li S, Rodrigues M, Rodriguez D, Rodriguez JR, Esteban M, Palese P, Nussenzweig RS, Zavala F: Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc.Natl.Acad.Sci.U.S.A 1993, 90: 5214–5218.

    Article  PubMed  CAS  Google Scholar 

  • Linette GP, Shankara S, Longerich S, Yang S, Doll R, Nicolette C, Preffer FI, Roberts BL, Haluska FG: In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*020 1 -restricted CD8+ T cells in patients with melanoma. J.Immunol. 2000, 164: 3402–3412.

    PubMed  CAS  Google Scholar 

  • Lusky M, Christ M, Rittner K, Dieterle A, Dreyer D, Mourot B, Schultz H, Stoeckel F, Pavirani A, Mehtali M: In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J.Virol. 1998, 72: 2022–2032.

    PubMed  CAS  Google Scholar 

  • Lyakh LA, Koski GK, Young HA, Spence SE, Cohen PA, Rice NR: Adenovirus type 5 vectors induce dendritic cell differentiation in human CD14(+) monocytes cultured under serum-free conditions. Blood 2002, 99: 600–608.

    Article  PubMed  CAS  Google Scholar 

  • Mackett M, Smith GL: Vaccinia virus expression vectors. J.Gen.Virol. 1986, 67:2067– 2082.

    Google Scholar 

  • Mangeot PE, Duperrier K, Negre D, Boson B, Rigal D, Cosset FL, Darlix JL: High levels of transduction of human dendritic cells with optimized SIV vectors. Mol.Ther. 2002, 5: 283–290.

    Article  PubMed  CAS  Google Scholar 

  • Markert JM, Medlock MD, Rabkin SD, Gillespie GY, Todo T, Hunter WD, Palmer CA, Feigenbaum F, Tornatore C, Tufaro F, Martuza RL: Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther. 2000, 7: 867–874.

    Article  PubMed  CAS  Google Scholar 

  • Maruyama K, Akiyama Y, Nara-Ashizawa N, Hojo T, Cheng JY, Mizuguchi H, Hayakawa T, Yamaguchi K: Adenovirus-mediated MUC1 gene transduction into human blood-derived dendritic cells. J.Immunother. 2001, 24: 345–353.

    Article  PubMed  CAS  Google Scholar 

  • Metharom P, Ellem KA, Schmidt C, Wei MQ: Lentiviral vector-mediated tyrosinaserelated protein 2 gene transfer to dendritic cells for the therapy of melanoma. Hum.Gene Ther. 2001, 12: 2203–2213.

    Article  PubMed  CAS  Google Scholar 

  • Meyer H, Sutter G, Mayr A: Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J.Gen.Virol. 1991, 72 (Pt 5): 1031–1038.

    Article  PubMed  CAS  Google Scholar 

  • Mikloska Z, Bosnjak L, Cunningham AL: Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J.Virol. 2001, 75:5958– 5964.

    Google Scholar 

  • Mineta T, Rabkin SD, Yazaki T, Hunter WD, Martuza RL: Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat.Med. 1995, 1: 938–943.

    Article  PubMed  CAS  Google Scholar 

  • Monahan PE, Samulski RJ: AAV vectors: is clinical success on the horizon? Gene Ther. 2000, 7: 24–30.

    Article  PubMed  CAS  Google Scholar 

  • Morelli AE, Larregina AT, Ganster RW, Zahorchak AF, Plowey JM, Takayama T, Logar AJ, Robbins PD, Falo LD, Thomson AW: Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J.Virol. 2000, 74: 9617–9628.

    Article  PubMed  CAS  Google Scholar 

  • Muzyczka N: Use of adeno -associated virus as a general transduction vector for mammalian cells. Curr.Top.Microbiol.Immunol. 1992, 158: 97–129.

    Article  PubMed  CAS  Google Scholar 

  • Negre D, Mangeot PE, Duisit G, Blanchard S, Vidalain PO, Leissner P, Winter AJ, Rabourdin-Combe C, Mehtali M, Moullier P, Darlix JL, Cosset FL: Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther. 2000, 7: 1613–1623.

    Article  PubMed  CAS  Google Scholar 

  • Palese P, Zheng H, Engelhardt OG, Pleschka S, Garcia-Sastre A: Negative-strand RNA viruses: genetic engineering and applications. Proc.Natl.Acad.Sci.U.S.A 1996, 93: 11354–11358.

    Article  PubMed  CAS  Google Scholar 

  • Pecher G, Spahn G, Schirrmann T, Kulbe H, Ziegner M, Schenk JA, Sandig V: Mucin gene (MUC1) transfer into human dendritic cells by cationic liposomes and recombinant adenovirus. Anticancer Res. 2001, 21: 2591–2596.

    PubMed  CAS  Google Scholar 

  • Philip R, Alters SE, Brunette E, Ashton J, Gadea J, Yau J, Lebkowski J, Philip M: Dendritic cells loaded with MART-1 peptide or infected with adenoviral construct are functionally equivalent in the induction of tumor-specific cytotoxic T lymphocyte responses in patients with melanoma. J.Immunother. 2000, 23: 168–176.

    Article  PubMed  CAS  Google Scholar 

  • Ponnazhagan S, Mahendra G, Curiel DT, Shaw DR: Adeno-associated virus type 2- mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy. J.Virol. 2001, 75: 9493–9501.

    Article  PubMed  CAS  Google Scholar 

  • Rea D, Havenga MJ, van Den AM, Sutmuller RP, Lemckert A, Hoeben RC, Bout A, Melief CJ, Offringa R: Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J.Immunol. 2001, 166: 5236–5244.

    PubMed  CAS  Google Scholar 

  • Rea D, Schagen FH, Hoeben RC, Mehtali M, Havenga MJ, Toes RE, Melief CJ, Offringa R: Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset. J Virol. 1999, 73: 10245–10253.

    PubMed  CAS  Google Scholar 

  • Ready T: Trials suspended due to death at Hopkins. Nat.Med. 2001, 7: 877.

    Article  PubMed  CAS  Google Scholar 

  • Roelvink PW, Lizonova A, Lee JG, Li Y, Bergelson JM, Finberg RW, Brough DE, Kovesdi I, Wickham TJ: The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J.Virol. 1998, 72: 7909–7915.

    PubMed  CAS  Google Scholar 

  • Rouard H, Leon A, Klonjkowski B, Marquet J, Tenneze L, Plonquet A, Agrawal SG, Abastado JP, Eloit M, Farcet JP, Delfau-Larue MH: Adenoviral transduction of human ‘clinical grade’ immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity. J Immunol Methods 2000, 241: 69–81.

    Article  PubMed  CAS  Google Scholar 

  • Salio M, Cella M, Suter M, Lanzavecchia A: Inhibition of dendritic cell maturation by herpes simplex virus. Eur.J.Immunol. 1999, 29: 3245–53.

    Article  PubMed  CAS  Google Scholar 

  • Schultz ES, Chapiro J, Lurquin C, Claverol S, Burlet-Schiltz O, Warnier G, Russo V, Morel S, Levy F, Boon T, Van den Eynde BJ, van der BP: The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome. J.Exp.Med. 2002, 195: 391–399.

    Article  PubMed  CAS  Google Scholar 

  • Sena-Esteves M, Saeki Y, Fraefel C, Breakefield XO: HSV-1 amplicon vectors–simplicity and versatility. Mol.Ther. 2000, 2: 9–15.

    Article  PubMed  CAS  Google Scholar 

  • Stevenson SC, Rollence M, White B, Weaver L, McClelland A: Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain. J.Virol. 1995, 69: 2850–2857.

    PubMed  CAS  Google Scholar 

  • Stockwin LH, Matzow T, Georgopoulos NT, Stanbridge LJ, Jones SV, Martin IG, Blair-Zajdel ME, Blair GE: Engineered expression of the Coxsackie B and adenovirus receptor (CAR) in human dendritic cells enhances recombinant adenovirus-mediated gene transfer. J.Immunol.Methods 2002, 259: 205–215.

    Article  PubMed  CAS  Google Scholar 

  • Strobel I, Krumbholz M, Menke A, Hoffmann E, Dunbar PR, Bender A, Hobom G, Steinkasserer A, Schuler G, Grassmann R: Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells, using an avian influenza virus vector. Hum.Gene Ther. 2000, 11: 2207–2218.

    Article  PubMed  CAS  Google Scholar 

  • Subklewe M, Chahroudi A, Schmaljohn A, Kurilla MG, Bhardwaj N, Steinman RM: Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV- inactivated, recombinant EBNA-3Avaccinia virus. Blood 1999, 94: 1372–1381.

    PubMed  CAS  Google Scholar 

  • Sutter G, Moss B: Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc.Natl.Acad.Sci.U.S.A 1992, 89: 10847–10851.

    Article  PubMed  CAS  Google Scholar 

  • Sydiskis RJ, Roizman B: Polysomes and protein synthesis in cells infected with a DNA virus. Science 1966, 153: 76–78.

    Article  PubMed  CAS  Google Scholar 

  • Tillman BW, de Gruijl TD, Luykx-de Bakker SA, Scheper RJ, Pinedo HM, Curiel TJ, Gerritsen WR, Curiel DT: Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector. J.Immunol. 1999, 162: 6378–6383.

    PubMed  CAS  Google Scholar 

  • Toes RE, Ossendorp F, Offringa R, Melief CJ: CD4 T cells and their role in antitumor immune responses. J.Exp.Med. 1999, 189: 753–756.

    Article  PubMed  CAS  Google Scholar 

  • Trevor KT, Hersh EM, Brailey J, Balloul JM, Acres B: Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2. Cancer Immunol.Immunother. 2001, 50: 397–407.

    Article  PubMed  CAS  Google Scholar 

  • Trono D: Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther. 2000, 7: 20–23.

    Article  PubMed  CAS  Google Scholar 

  • Wickham TJ, Mathias P, Cheresh DA, Nemerow GR: Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993, 73: 309–319.

    Article  PubMed  CAS  Google Scholar 

  • Wold WS, Gooding LR: Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 1991, 184: 1–8.

    Article  PubMed  CAS  Google Scholar 

  • Yang Y, Wilson JM: Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J.Immunol. 1995, 155: 2564–2570.

    PubMed  CAS  Google Scholar 

  • Zachos G, Clements B, Conner J: Herpes simplex virus type 1 infection stimulates p38/c-Jun N-terminal mitogen-activated protein kinase pathways and activates transcription factor AP-1. J.Biol.Chem. 1999, 274: 5097–5103.

    Article  PubMed  CAS  Google Scholar 

  • Zhong L, Granelli-Piperno A, Choi Y, Steinman RM: Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Eur.J.Immunol. 1999, 29: 964–972.

    Article  PubMed  CAS  Google Scholar 

  • Zhu M, Terasawa H, Gulley J, Panicali D, Arlen P, Schlom J, Tsang KY: Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells. Cancer Res. 2001, 61:3725– 3734.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Erlangen, Hartmannstrasse 14, 91052, Erlangen, Germany

    J. Humrich & L. Jenne

Authors
  1. J. Humrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Jenne
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dermatologische Klinik, Universität Erlangen, Hartmannstr. 14, 91052, Erlangen, Germany

    Alexander Steinkasserer

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Humrich, J., Jenne, L. (2003). Viral Vectors for Dendritic Cell-Based Immunotherapy. In: Steinkasserer, A. (eds) Dendritic Cells and Virus Infection. Current Topics in Microbiology and Immunology, vol 276. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06508-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-06508-2_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-07926-9

  • Online ISBN: 978-3-662-06508-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation